Clinical trials
Observational Leukemia, Myeloid, Acute trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Terminated | 4 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Technische Universität Dresden | 2 |
| University of Freiburg | 2 |
| University of Ulm | 2 |
| iOMEDICO AG | 2 |
| AvenCell Therapeutics, Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Exscientia AI Limited | 1 |
| Hannover Medical School | 1 |
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 1 |
| Kiadis Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 18 |
| Graft vs Host Disease | 2 |
| Hematologic Neoplasms | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Myelodysplastic Syndromes | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Recurrence | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blast Crisis | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.